Liquid Biopsy

Global Market Trajectory & Analytics

MCP13050

EXECUTIVE ENGAGEMENTS

OUTREACH

1784
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

321
Interactions with Platform & by Email

PARTICIPANTS

71
Unique # Participated

VALIDATIONS

16
Responses Validated*

COMPETITORS

42
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

76

PAGES

148

EDITION

9

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Liquid Biopsy estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 20.2% over the analysis period 2020-2027. Lung, one of the segments analyzed in the report, is projected to record a 20.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Breast segment is readjusted to a revised 21.5% CAGR for the next 7-year period.
The Liquid Biopsy market in the U.S. is estimated at US$315 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$672.3 Million by the year 2027 trailing a CAGR of 19.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 17.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.
In the global Colorectal segment, USA, Canada, Japan, China and Europe will drive the 19.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$144.5 Million in the year 2020 will reach a projected size of US$502.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$447.7 Million by the year 2027.

SELECT PLAYERS

Biocept, Inc.; Bio-Rad Laboratories, Inc.; Genomic Health, Inc.; Guardant Health, Inc.; Illumina, Inc.; MDxHealth SA; Menarini Silicon Biosystems Spa; Myriad Genetics, Inc.; Qiagen NV; RainDance Technologies, Inc.; Roche Diagnostics (Schweiz) AG; Thermo Fisher Scientific, Inc.; TrovaGene, Inc.

SEGMENTS

» Cancer Type (Lung, Breast, Colorectal, Prostate, Liver, Other Cancer Types) » Product (Instruments, Assay Kits, Reagents)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Liquid Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Liquid Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Prostate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
USA Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Canada Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Japan Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
China Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Liquid Biopsy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Liquid Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Europe Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
France Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Germany Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Italy Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
UK Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Liquid Biopsy by Cancer Type - Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Liquid Biopsy by Cancer Type - Percentage Breakdown of Value Sales for Lung, Breast, Colorectal, Prostate, Liver and Other Cancer Types for the Years 2020 & 2027
Rest of World Current & Future Analysis for Liquid Biopsy by Product - Instruments, Assay Kits and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Liquid Biopsy by Product - Percentage Breakdown of Value Sales for Instruments, Assay Kits and Reagents for the Years 2020 & 2027
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com